Integra LifeSciences Holdings vs. Stryker Corporation
Stryker Corporation (SYK) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| IART | SYK | |
|---|---|---|
| Market Cap | $1.25 billion | $104.70 billion |
| Revenue (TTM) | $1.65 billion | $25.84 billion |
| Net Income (TTM) | $-7,242,000 | $3.73 billion |
SYK leads on 3 of 3 size & scale factors.
Valuation
| IART | SYK | |
|---|---|---|
| P/E Ratio | — | 28.54 |
| Price / Book | 1.20 | 4.36 |
| Price / Sales | 0.76 | 4.05 |
IART leads on 2 of 2 valuation factors.
Profitability
| IART | SYK | |
|---|---|---|
| Net Margin | -0.44% | 14.43% |
| Return on Equity | -0.69% | 15.55% |
SYK leads on 2 of 2 profitability factors.
Dividend
| IART | SYK | |
|---|---|---|
| Dividend Yield | — | 1.28% |
| Payout Ratio | — | 36.48 |
IART and SYK split the dividend factors evenly.
Risk & Sentiment
| IART | SYK | |
|---|---|---|
| Short Interest | 6.92% | 1.53% |
SYK leads on 1 of 1 risk & sentiment factors.
Dig deeper: IART overview, IART financials, SYK overview, SYK financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.